With humans, it is likely more complex but identifying the neural correlates of expectation may help produce more effective pain relief in humans and animals.
Read More ›
The placebo effect may be getting stronger as researchers manipulate it more effectively.
Read More ›We don’t often hear about researchers crying but when researchers at Ovid Therapeutics heard the test results for their drug, gaboxadol, they couldn’t help it. They were testing the sleep-inducing drug to help with the symptoms of Angelman Syndrome, a rare neurogenetic disorder that appears in infancy. It results in a variety of developmental problems such as walking and balance disorders, inability to speak or sleep properly, gastrointestinal issues, and seizures. It affects people in different ways and to different degrees. Notably, those who cope with Angelman smile and laugh a lot and have a normal lifespan. The OVID team had high hopes for gaboxadol in August of this year because even improving the quality of sleep would help sufferers Read More ›
It sounds as though too many people know too much about what to expect for any raw data about human cognition to be recovered from the Rubber Hand illusion.
Read More ›
In the Information Age, we face a problem our ancestors did not face: far too much information. Our challenge is learning how to know when we have all the information we need to calmly make decisions we can live with.
Read More ›
The fact that you may start to get better if you believe you are receiving treatment is one of the best-attested facts in medicine. Despite that, far from being accepted, this “placebo effect” is seen in many quarters as, at best, a “pesky thing” and at worst, a “trick,” if not a “fraud.” Perhaps that is due to a drive to reduce medical science to the purely physical.
Read More ›